- Title: Subtitle
- Tu2023 EXPLORING THE ROLE OF VOLIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR, IN THE REGULATION OF IL-31 AND SERUM BILE ACIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: PRELIMINARY RESULTS FROM THE VANTAGE TRIAL
- Creators
- Mitchell L. ShiffmanAlan BonderDebra WeinsteinVictor Ankoma-SeyNimer AssyDian-Jung ChiangMaurizia BrunettoJonel TrebickaCurtis FreedlandLisa FormanAntonio J. SanchezQiang CaiHrishikesh SamantNatasha Von RoennJohn E. EatonNyingi KemmerJiten P. KothadiaChirag PatelSuresh V. VenkatachalapathyEhud ZigmondEli ZuckermanRoberto Firpi-MorellTh. Till WissniowskiBrian BorgHesham ElGouhariManish ThaparNeha AgrawalJustin R. BoikeFrancois HabersetzerAna LleoAlexandre LouvetRoger McCorryGuy NeffColeman SmithAlbert TranRaffaella ViganoFrank E. UschnerMaximilian J. BrolYooyun ChungIlkay ErgencTiago NunesHallam GugelmannJilliann ElliottTobias Di MarcoJayshree KrishnaswamiRaul AguilarJoanne QuanPamela VigMICHAEL A. HeneghanKris V. Kowdley
- Resource Type
- Abstract
- Publication Details
- Gastrointestinal endoscopy, Vol.103(5 Supplement), p.S-1693
- DOI
- 10.1016/S0016-5107(26)04045-9
- ISSN
- 0016-5107
- Publisher
- Elsevier
- Language
- English
- Date published
- 05/2026
- Academic Unit
- Gastroenterology and Hepatology; Internal Medicine
- Record Identifier
- 9985163398802771
Abstract
Tu2023 EXPLORING THE ROLE OF VOLIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR, IN THE REGULATION OF IL-31 AND SERUM BILE ACIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: PRELIMINARY RESULTS FROM THE VANTAGE TRIAL
Gastrointestinal endoscopy, Vol.103(5 Supplement), p.S-1693
05/2026
DOI: 10.1016/S0016-5107(26)04045-9
Details
Metrics
1 Record Views